22 January 2020 | News, Press Releases,
Global Kinetics Pty Ltd., a digital health company focused on the development and commercialization of the Personal KinetiGraph® (PKG®), the first FDA-cleared and CE-marked platform for the objective measurement of movement symptoms in the management of Parkinson’s disease, today announced the appointment of Matthew C. Garrett, an experienced financial executive in the life sciences industry, as an independent director to its Board of Directors.